It should not be considered medical advice nor intended to replace the advice of a healthcare professional
Beyond weight management, GLP-1 receptor agonists exhibit additional cardioprotective effects
See Important Safety Information about GLP-1 medications, including Boxed Warning, at ro.co/safety
As with any research peptide, observations may vary depending on laboratory conditions, research models, and study objectives
However, when combined with sulphonylureas or insulin, the risk increases significantly, and doses of these medications may need reduction under clinical supervision to prevent low blood glucose and associated dizziness
Clinical Director at Drip Lounge